Ambit Iberia and Applus+ Laboratories join forces to drive innovation in Life Sciences

Marta Herrera,


Ambit Iberia, a consultancy specialising in Life Sciences with over 20 years of experience, and Applus+ Laboratories, the Applus+ Group division specialising in testing and certification services, have announced a strategic collaboration to strengthen support for companies in the sector in their innovation, digital transformation and regulatory compliance processes.

The alliance combines Ambit Iberia's consultancy expertise for the pharmaceutical, biotechnology, digital solutions and medical device industries with Applus+ Laboratories' technical knowledge and testing, validation and certification capabilities. Through this partnership, clients will gain access to a comprehensive service combining strategic consultancy, digital transformation, qualification, calibration, validation and regulatory compliance.

Ambit Iberia brings a strong track record supporting organisations in digitalising their processes, while Applus+ Laboratories offers qualification, calibration, validation and instrumentation supply services throughout the lifecycle of equipment and systems, backed by state-of-the-art facilities and compliance with international standards such as GMP and ISO.

"This collaboration is a strategic step in continuing to offer our clients an increasingly complete and specialised service. We share with Applus+ Laboratories a vision built on excellence, innovation and commitment to the Life Sciences sector," says Brismark Antoniony, Managing Partner at Ambit Iberia.

David Cabré, Head of Metrology at Applus+ Laboratories, adds: "This alliance will generate significant synergies and offer a differentiated proposal combining Applus+ Laboratories' technical knowledge with Ambit Iberia's consulting expertise, bringing greater value to our clients."

At Catalonia.health, we're glad to see this kind of connection taking shape within the ecosystem, as two member companies join forces to offer the sector a stronger service.

Comments


To comment, please login or create an account
Modify cookies